🦠
MicroDAO Whitepaper
  • MICRO: Funding the next generation of AMR Solutions: Antimicrobials, Diagnostics, and Vaccines
    • Executive Summary
    • The AMR Challenge
      • Understanding Antimicrobial Resistance
      • The Human Innovation Gap
      • Investments into AMR solutions
    • microDAO: A Community-Driven Solution to Tackle AMR
      • Vision and Mission
      • Operational Framework
      • Structure of microDAO
        • Core Team
        • Community Members
        • Token Holders
        • Working Groups
        • Service Providers
        • Partners
        • End users of solutions and funding offered by microDAO
    • DAO Way of Working
    • microDAO’s Flywheel for Impact and Revenue: Community Tools and Workflows
      • Evidence Generation & Decision Support Tools
      • R&D Acceleration Tools
    • microDAO Revenue Streams: Building Sustainable Impact
    • Fund Allocation Strategy for liquid funds available in the DAO treasury
      • Strategic Priority Areas
        • Early-Stage Research Development
        • Clinical Development Support
        • Equitable Access Programmes
        • Infrastructure and Tools
        • Operational Sustainability
    • Impact and Future Outlook
Powered by GitBook
On this page
  1. MICRO: Funding the next generation of AMR Solutions: Antimicrobials, Diagnostics, and Vaccines
  2. microDAO: A Community-Driven Solution to Tackle AMR
  3. Structure of microDAO

Community Members

Community members are stakeholders invested in the mission of finding solutions to lower the burden of AMR. They include researchers, innovators and tool builders who share insights, propose solutions and contribute to the development of new antimicrobials, vaccines and diagnostic tools. Community members also support and promote the responsible use of antimicrobials and ensure that the wider community is aware and has access to innovative tools.

PreviousCore TeamNextToken Holders

Last updated 6 months ago